Bankwell Financial Group, Inc.'s filings document the holding company's ownership of Bankwell Bank and recurring disclosures for a commercial banking issuer. Form 8-K reports furnish quarterly results of operations and financial condition, Regulation FD presentation materials, and trends in profitability, loan growth, deposits, funding costs, net interest margin, credit quality and SBA lending activity.
Definitive proxy materials cover annual meeting governance, director matters, executive compensation, equity awards and shareholder voting items. The filings also record the company's Connecticut incorporation, public-company identifiers, furnished earnings releases and exhibits used to report financial results and presentation materials.
Bankwell Financial Group, Inc. reported stronger results for the quarter ended June 30, 2026. Net income was $12,372 thousand for the quarter and $23,647 thousand for the first six months, compared with $9,088 thousand and $15,976 thousand a year earlier. Basic and diluted EPS for the quarter were $1.55 and $1.52, with dividends of $0.20 per share in the quarter and $0.40 year-to-date. Higher net interest income and significantly larger gains and fees from loan sales contributed to the increase, while noninterest expenses rose mainly from salaries and employee benefits.
Total assets were $3,475,570 thousand at June 30, 2026, with loans of $2,959,693 thousand and deposits of $3,000,530 thousand, all above December 31, 2025 levels. The allowance for credit losses on loans was $30,627 thousand, essentially unchanged, while nonaccrual loans were $15,857 thousand. Capital ratios exceeded regulatory “well capitalized” thresholds, with Bankwell Bank reporting a Common Equity Tier 1 ratio of 11.67% and a Tier 1 leverage ratio of 10.39%.
Bankwell Financial Group, Inc. Chief Innovation Officer Ryan Jason Hildebrand reported a sale of 2,246 shares of common stock on July 31, 2026 at a reported price of $66.74 per share, with individual sale prices ranging from $65.99 to $67.05.
He has also been granted 15,000 performance restricted shares that cliff vest on February 7, 2028 if performance goals are achieved, and 3,116 restricted shares split equally between time-based vesting from February 7, 2027 and performance-based vesting on February 7, 2029, all under the 2022 stock plan.
Bankwell Financial Group, Inc. reports that affiliate Ryan Jason Hildebrand plans to sell 2,246 shares of common stock, to be traded on NASDAQ, with an aggregate market value of $149,906.00 and an expected sale date of July 31, 2026.
The shares originate from retained shares from restricted stock vesting classified as compensation. In the past three months, Hildebrand previously sold 1,088 shares of common stock on July 1, 2026 for an aggregate value of $63,626.24.
BlackRock, Inc. reports passive ownership of common stock of Bankwell Financial Group, Inc. under a Schedule 13G filing. BlackRock and specified reporting business units beneficially own 416,427 shares of Bankwell common stock, representing 5.2 % of the outstanding class.
BlackRock has sole voting power over 408,734 shares and sole dispositive power over 416,427 shares, with no shared voting or dispositive power reported. Various underlying clients have rights to dividends or sale proceeds, but no single client holds more than five percent of Bankwell’s total outstanding common shares.
Bankwell Financial Group reported strong Q2 2026 results, with GAAP net income of $12.4 million and diluted EPS of $1.52, up from $11.3 million and $1.41 in Q1. Profitability metrics were solid, including a 1.46% return on average assets and 15.61% return on average tangible common equity. Pre-tax, pre-provision net revenue rose 31.4% quarter-over-quarter to $17.5 million as net interest income increased to $29.5 million and net interest margin expanded to 3.58%. The efficiency ratio improved to 47.5%.
Core deposits grew $128 million while gross loans increased $93.1 million to about $3.0 billion, allowing wholesale funding and brokered deposits to decline. Asset quality remained favorable: nonperforming assets fell to 0.46% of total assets and the $30.6 million allowance for credit losses on loans covered 193% of nonperforming loans. Shareholders’ equity reached $323.5 million and fully diluted tangible book value per share rose to $40.25. The board declared a $0.20 quarterly dividend. Management updated 2026 guidance, raising net interest income to $115–$117 million and loan growth to 5–7%, while lifting noninterest expense guidance to $65–$67 million but expecting no adverse impact on the 2026 efficiency ratio.
Bankwell Financial Group, Inc. Chief Innovation Officer Ryan Jason Hildebrand reported a share sale tied to tax withholding on recently vested stock. On July 1, 2026, 1,088 shares of common stock were sold at $58.48 per share through the company’s cashless stock exercise program to cover tax liabilities on the vesting of 3,334 shares.
After this transaction, he directly holds 2,246 common shares. In addition, he holds 15,000 performance restricted shares granted under the 2022 Stock Plan, which have a three-year cliff vesting on February 7, 2028 if performance goals are met. He also holds 3,116 restricted and performance restricted shares from the same plan, with half vesting in three equal annual installments starting February 7, 2027 and half subject to three-year cliff vesting on February 7, 2029 based on performance.
Bankwell Financial Group, Inc. Chief Innovation Officer Ryan Jason Hildebrand reported a proposed sale of 1,088 common shares, with an aggregate market value of $63,625.70 and an approximate sale date of July 1, 2026. The notice says the shares are being sold pursuant to the vesting and settlement of equity awards to cover obligations. It also reports 3,334 common shares acquired through restricted stock vesting for services rendered on July 1, 2026.
Bankwell Financial Group director Lawrence B. Seidman reported an indirect open-market purchase of Bankwell common stock. On June 5, 2026, a Deferred Compensation Plan associated with him bought 323 shares at $53.70 per share, increasing that plan’s holdings to 4,844 shares.
The filing also lists Seidman’s other direct and indirect holdings through several investment entities, along with multiple restricted stock grants that are scheduled to vest in tranches between 2026 and 2029 under Bankwell’s stock plans.
Bankwell Financial Group director Eric J. Dale reported an open-market purchase of common stock. On June 5, 2026, he bought 588 shares of Bankwell Financial Group, Inc. common stock at $53.70 per share through a Deferred Compensation Plan, increasing his indirect holdings there to 42,496 shares.
Separate entries show direct holdings of Bankwell common stock and multiple restricted stock grants under the 2022 Bankwell Financial Group, Inc. Stock Plan with scheduled vesting dates through 2029. As of the filing date, the footnotes state that 1,200, 1,066, and 600 shares from different grants have vested.
Bankwell Financial Group, Inc. director Blake S. Drexler reported a small open-market purchase of 79 shares of common stock at $53.70 per share on June 5, 2026, through a Deferred Compensation Plan, bringing that plan’s holdings to 36,933 shares.
The filing also updates his broader ownership picture, including 160,861 shares held directly, 58,224 shares held by family members over which he exercises effective control, and 1,128 shares held through an IRA/401(k), along with several tranches of restricted stock granted under company stock plans with scheduled vesting over future years.